EP3362070
COMBINATION OF A MUTANT ISOCITRATE DEHYDROGENASE 2 INHIBITOR WITH AZACITIDINE AND ITS USE FOR TREATING ACUTE MYELOGENOUS LEUKEMIA
:
EP einkaleyfi: Þýðing ekki lögð inn:
14.10.2016:
27.1.2021:
16788866.8
:
13.10.2036
:
COMBINATION OF A MUTANT ISOCITRATE DEHYDROGENASE 2 INHIBITOR WITH AZACITIDINE AND ITS USE FOR TREATING ACUTE MYELOGENOUS LEUKEMIA
14.10.2016
27.1.2021
:
Celgene Corporation:
86 Morris Avenue, Summit, NJ 07901, US
:
Agios Pharmaceuticals, Inc.:
88 Sidney Street, Cambridge, MA 02139, US
:
CHOPRA, Vivek, Saroj, Kumar:
South San Francisco, CA 94080, US
:
DIMARTINO,Jorge:
Belmont, CA 94002, US
:
KENVIN, Laurie, A.:
New Hope, PA 18938, US
:
KNIGHT, Robert, Douglas:
Berkeley Heights, NJ 07922, US
:
MACBETH, Kyle:
San Francisco, CA 94103, US
:
VISWANADHAN, Krishnan:
East Hanover, NJ 07936, US
:
XU, Qiang:
Basking Ridge, NJ 07920, US
:
AGRESTA, Samuel, V.:
Lexington, MA 02420, US
:
201562242218 P:
15.10.2015:
US
:
US2016057102:
14.10.2016
:
A61K 31/53, A61K 31/7068, A61P 35/00, A61P 35/02, A61K 45/06, A61K 9/00